UBS analyst Steven Fisher raised the firm’s price target on Primoris to $34 from $29 and keeps a Buy rating on the shares. Primoris had a "solid" Q4, with an "uneventful" release for the second quarter in a row, the analyst tells investors in a research note. The firm is encouraged by the improvement in margins since Q1, which it attributes partially to better cost management and improved execution.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PRIM: